| 9/15/2025 | PV | Team issues $75 million series B preferreds, amends loan agreements
|
| 9/11/2025 | PV | Team increases ABL credit facility to $150 million, reduces margin of first-lien term loan
|
| 3/13/2025 | BK | Team gets $225 million first-lien term loan, restates second-lien loan
|
| 9/30/2024 | PV | Team amends ABL facility to extend to 2027, lower rate adjustment
|
| 6/21/2023 | BKPV | Team revises terms, upsizes amounts of loans from Corre, Eclipse
|
| 5/25/2023 | PV | Team secures committed term loan financing from Corre, Eclipse
|
| 12/22/2022 | CV | Team adjusts conversion rate for 5% convertibles after reverse split
|
| 11/10/2022 | PV | Team amends term loans to ease maximum net leverage ratio covenants
|
| 2/11/2022 | PV | Team refinances ABL, ups facility size to $165 million
|
| 12/18/2020 | CVLM | Team to repurchase $137 million of 5% convertibles for $136 million
|
| 12/18/2020 | BKPV | Team signs new $250 million term loan led by Atlantic Park
|
| 9/6/2019 | BK | Team cuts borrowing capacity to $275 million, extends maturity to 2021
|
| 3/9/2018 | BK | Team amends secured credit facility with BofA to modify covenants
|
| 7/26/2017 | CV | Market Commentary: U.S. convertibles narrowly mixed; new Team lifts 1.5 points on swap; AMD jumps on earnings
|
| 7/26/2017 | CV | Market Commentary: Morning Commentary: New Team convertibles lift 1.5 points on swap; AMD jumps on positive earnings
|
| 7/26/2017 | CV | New Issue: Team sells upsized $200 million convertible notes due 2023 to yield 5%, up 40%
|
| 7/25/2017 | CV | Market Commentary: Novavax loses ground; Pacira trial results disappoint; Medicines’ data positive, bonds flat
|
| 7/25/2017 | CV | Market Commentary: Morning Commentary: WebMD remains active but holds steady; new issue from Team on deck
|
| 7/24/2017 | CV | Market Commentary: WebMD convertibles jump on KKR purchase news; Arconic results beat as bonds wane; Novavax up
|
| 7/24/2017 | BK | Team plans to fully repay term loan with proceeds of convertibles
|
| 7/24/2017 | CV | Team to sell $175 million of six-year convertible notes; price talk 4.75%-5.25%, up 37.5%-42.5%
|
| 8/23/2016 | BK | Team revises maximum leverage schedule, adds level to pricing grid
|
| 3/1/2016 | BK | Team increases revolver to $400 million via Monday amendment
|
| 7/9/2015 | BK | Team’s amended facility priced at Libor plus 125 bps to 225 bps
|
| 7/6/2015 | BK | Team expands credit facility to $500 million for Qualspec acquisition
|
